Today: November 13, 2024
Today: November 13, 2024

Latest From Andrew Silver

Asia|Business|Economy|Europe|World

EU does not want trade war with Beijing, says bloc's ambassador to China

The EU does not want a trade war with Beijing but five years of talks have yielded no real progress, the bloc's ambassador to China said on Saturday, adding that

EU does not want trade war with Beijing, says bloc's ambassador to China
Asia|Health|Science

Exclusive-Eisai expects 1,500 Alzheimer's patients in China launch, sees ‘huge’ growth

Japan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects

Exclusive-Eisai expects 1,500 Alzheimer's patients in China launch, sees ‘huge’ growth
Asia|Business|Economy|Health|US

US tariffs on Chinese medical imports face industry doubt as alternative suppliers emerge

Higher U.S. tariffs on medical gloves, syringes and face masks from China are unlikely to make U.S. producers more competitive,

US tariffs on Chinese medical imports face industry doubt as alternative suppliers emerge
Asia|Business|Health|Science|Technology|US

Staff at drugmaker under U.S. scrutiny worked with Chinese military scientists

Employees of drugmaker WuXi AppTec, under U.S. scrutiny for its links to the Chinese military, co-invented altitude sickness treatments

Staff at drugmaker under U.S. scrutiny worked with Chinese military scientists
Asia|Business|Health|US

Drug giants eye China for deals despite growing Sino-US tensions

Some of the biggest global drugmakers, undeterred by mounting Sino-U.S. tensions, are scouring for deals in China to replenish drug

Drug giants eye China for deals despite growing Sino-US tensions
Asia|Business|Economy

China's economic malaise seen accelerating obesity rates

As China builds fewer houses and bridges, its consumers buy cheaper, less-healthy meals, and as factories and farms invest in

China's economic malaise seen accelerating obesity rates
Asia|Business|Health|World

How Asian pharma suppliers cash in on Ozempic copies

Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro and Orsema, developed by a little-known

How Asian pharma suppliers cash in on Ozempic copies
Business|Science

China approves CSPC Pharma mRNA cancer therapy for clinical trials

A cancer cell therapy from CSPC Pharmaceutical Group that uses synthetic messenger RNA (mRNA) technology has received regulatory clearance in China for human

Asia|Business|Health

India's Biocon seeks partner to test generic Wegovy, Ozempic in China

India's Biocon is searching for a partner in China to test generic versions of Novo Nordisk's hot-selling diabetes drug Ozempic and weight loss treatment Wegovy,

Business|Economy|Health

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China

Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Asia|Business|Health|World

Novo Nordisk's Wegovy weight-loss drug approved in China

Novo Nordisk's hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world's second-largest economy and the country estimated

Novo Nordisk's Wegovy weight-loss drug approved in China
Business|Economy|Finance|Stock Markets|Technology|US

US bill poses risk to Wuxi AppTec and its Western drugmaker partners

A draft U.S. bill that has triggered a sell-off in shares of China's biotech firm Wuxi Apptec could deal a major blow not just to the firm but could also impact

US bill poses risk to Wuxi AppTec and its Western drugmaker partners
Asia|Business|Technology

Thermo Fisher halts forensic tech sales in Tibet

Thermo Fisher Scientific has pledged to stop selling forensic technology and equipment in Tibet that could be used for identifying individuals, a spokesperson for

Thermo Fisher halts forensic tech sales in Tibet
Asia|Business|Health|Science

Eli Lilly's weight loss drug tirzepatide gets approval in China

Eli Lilly said in a social media post Friday its weight loss drug tirzepatide had received approval from Chinese regulators, further intensifying competition with

Eli Lilly's weight loss drug tirzepatide gets approval in China
Asia|Business|Health|Science|Technology

China's drugmakers can't sell mRNA shots but haven't quit yet

China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA

China's drugmakers can't sell mRNA shots but haven't quit yet
Asia|Health|News|Science|World

Scientists see risk of lost opportunity for long COVID research in China

With more than a full year past since China eased restrictions and let COVID-19 sweep its households, scientists are worried a unique opportunity may be slipping

Scientists see risk of lost opportunity for long COVID research in China

Follow